Sorrento Therapeutics, Lonza Joint Venture To Use GS technology

Lonza, Sorrento form therapeutic antibodies JV

9:19 AM, 7th August 2013
sorrento therapeutics New Agreement with Lonza
Henry Ji, PhD, President and CEO, Sorrento Therapeutics.

BASEL, SWITZERLAND/SAN DIEGO, US: Sorrento Therapeutics Inc and Lonza will sign a non-exclusive research license agreement, for access to Lonza’s GS Xceed Gene Expression System. The GS Xceed System will be used in the generation of stable expression cell lines for the production and development of therapeutic antibodies in Sorrento’s product portfolio.

The research license agreement will give Sorrento access to Lonza’s GS technology for use in Sorrento’s maturing pipeline of therapeutic antibodies in oncology, inflammation, and infectious disease.

“We are excited to license Lonza’s GS Xceed System for the development of our lead human therapeutic antibody programme. The speed and ease of use of the GS Xceed System will aid in the rapid selection of high-producing cell lines and accelerate the production and development of our most promising therapeutic candidates,” said Henry Ji, PhD, President and CEO, Sorrento Therapeutics.

 

© Worldofchemicals News

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


Foster Wheeler awarded contract for iron ore mines study in Liberia

ZUG, SWITZERLAND: Foster Wheeler’s Global Engineering and Construction subsidiary has been awarded a concept study by Western Cluster Limited (W ...

Read more
World’s first lab grown beef burger …

LONDON, UK: Mark Post, Professor, Maastricht University has revealed a cultured beef burger at an event in London. As the world’s population gro ...

Read more
Mosaic, Ma’aden, SABIC JV for phosphate facility in Saudi Arabia

PLYMOUTH, US: The Mosaic Company has entered into a shareholders’ agreement with Saudi Arabian Mining Company (Ma’aden) and Saudi Basic In ...

Read more
Asahi Glass to increase chlor-alkali capacity in Indonesia

TOKYO, JAPAN: Asahi Glass Co Ltd (AGC) will invest approximately ¥40 billion ($406 million) to significantly increase the production capacity of i ...

Read more
Foster Wheeler awarded Enterprise’s PDH unit contract in Texas, US

ZUG, SWITZERLAND: The Global Engineering and Construction Group subsidiary of Foster Wheeler AG has been awarded an engineering, procurement and const ...

Read more
Momentive, MicroBlend to establish JV company in Cali, Colombia

COLUMBUS, US: Momentive Specialty Chemicals Inc (MSC) and MicroBlend Inc have formed a new joint venture company located in Cali, Colombia. The new co ...

Read more